高血压左室肥厚与血金属蛋白酶抑制因子和脑钠素的关系

暂未订购

导出

作者程震锋韦凡平何建方戴利成

机构地区浙江省湖州市中心医院心内科

出处《浙江临床医学》 2004年第12期1052-1053,共2页 Zhejiang Clinical Medical Journal

关键词金属蛋白酶抑制因子 BNP 脑钠素左室肥厚高血压金属蛋白酶组织抑制因子心室水平变化产生

参考文献7

1[1]Spinale FG,Coker ML, Bond BR,et al. Myocardial matrix degradation and metallopro teinases activation in failing heart: a potential therapeutic target.Cardiovasc Res, 2000,46(2): 225 ～ 238.
2[2]John G, Lainchbury A, Mark Richards M, et al. The effects of pathoph ysiological increments in brain natriuretic peptide in left ventricular sys tolic dysfunction. Hypertension, 1997,30: 398.
3[3]Palatini P, Visentin P, Mormino P, et al. Structural abnormalities and not diastolic dysfuntion are the earliest left ventricular changes in hyperten sion. Am J Hypertens, 1998, (3) 11: 147 ～ 156.
4[4]Diez J,Panizo A,Gil MJ,et al. Serum markers of collagen type Ⅰ metabolism in spontaneously hypertensive rat: relation to myocardial fibrosis.Circilation, 1996,93(5): 1026～ 1032.
5[5]Peterson JT, Li H, Dillon L, et al. Evolution of matrix metalloproteinase and tissue inhibitor expression during heart failure progression in the in farcted rat. Cardiovasc Res,2000,46(2) :307 ～ 315.
6[6]Li - Saw - Hee FL,Edmunds E,Blann AD,et al. matrix metalloprotein ases - 9 and tissue inhibitor metalloproteinase - 1 levels in essential hy pertension. Relationship to left ventricular mass and anti - hypertensive therapy. Int J Cardiol, 2000,75 (1): 43 ～ 47.
7[7]Buckley MG, Markandu ND, Miller MA, et al. Plasma concentrations and comparisons of brain and atrial natriuretic peptide in normal subjects and in patients with essential hypertension. J Hum Hypertens, 1993,7(3):245 ～ 250.

浙江临床医学

2004年第12期

内容加载中请稍等...